In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19

SARS-CoV-2 has caused millions of infections and hundreds of thousands of deaths globally. Presently, no cure for SARS-CoV-2 infection is available; thus, all hands are on deck for new drug discovery. Although, several studies have reported the potentials of some already approved drugs for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Adegbola, Peter Ifeoluwa, Fadahunsi, Olumide Samuel, Adegbola, Aanuoluwa Eunice, Semire, Banjo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295030/
https://www.ncbi.nlm.nih.gov/pubmed/34312587
http://dx.doi.org/10.1007/s40203-021-00105-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295030/
https://www.ncbi.nlm.nih.gov/pubmed/34312587
http://dx.doi.org/10.1007/s40203-021-00105-x

Ejemplares similares